Measurement of the modification and interference rate of urinary albumin detected by size-exclusion HPLC

Physiological Measurement

Volumn 30, Issue 10, 2009, Pages 1137-1150

  Markó, Lajos ^a   Molnár, Gergö Attila ^a   Wagner, Zoltán ^a   Böddi, Katalin ^a   Koszegi, Tamas ^a   Szabó, Zoltan ^a   Matus, Zoltan ^a   Szijrtó, Istvan ^a   Mérei, Äkos ^a   Nagy, Géza ^b   Wittmann, Istvan ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Albumin modification; Albuminuria; Diabetes; High performance liquid chromatography; Peak purity; Renal function

Indexed keywords

MEDICINE;

ALBUMIN MODIFICATION; ALBUMINURIA; CLINICAL OUTCOME; DIABETICS PATIENTS; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; INTERFERENCE RATE; MEASUREMENTS OF; PEAK PURITIES; RENAL FUNCTIONS; SIZE EXCLUSION;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ALBUMIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; URINALYSIS;

EID: 70350463842     PISSN: 09673334     EISSN: 13616579     Source Type: Journal    
DOI: 10.1088/0967-3334/30/10/012     Document Type: Article

References (34)

1. Agarwal R 2005 On the nature of proteinuria with acute renal injury in patients with chronic kidney disease Am. J. Physiol. Renal Physiol. 288 F265-71
2. American Diabetes Association 2007 Standards of medical care in diabetes 2007 Diabetes Care 30 S4-41
3. Brinkman J W, Bakker S J, Gansevoort R T, Hillege H L, Kema I P, Gans R O, de Jong P E and de Zeeuw D 2004 Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC Kidney Int. 92 S69-75
4. Brinkman J W, de Zeeuw D and Lambers Heerspink H J 2007 Apparent loss of urinary albumin during long-term frozen storage HPLC versus immunonephelometry Clin. Chem. 53 1520-6
5. Brownlee M 1995 Advanced protein glycosylation in diabetes and aging Annu. Rev. Med. 46 223-34
6. Cavallo-Perin P, Chiambretti A, Calefato V, Tomalino M, Cecchini G, Gruden G and Pagano G 1992 Urinary excretion of glycated albumin in insulin-dependent diabetic patients with micro- and macroalbuminuria Clin. Nephrol. 38 9-13
7. Cockcroft D W and Gault M H 1976 Prediction of creatinine clearance from serum creatinine Nephron 16 31-41
8. Cohen M P, Lautenslager G T, Hud E, Shea E, Wang A, Chen S and Shearman C W 2007 Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency Am. J. Physiol. Renal. Physiol. 292 F789-95
9. Comper W D, Jerums G and Osicka T M 2004a Differences in urinary albumin detected by four immunoassays and high-performance liquid chromatography Clin. Biochem. 37 105-11
10. Comper W D, Osicka T M, Clark M, MacIsaac R J and Jerums G 2004b Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay Kidney Int. 65 1850-5
11. Comper W D, Osicka T M and Jerums G 2003 High prevalence of immuno-unreactive intact albumin in urine of diabetic patients Am. J. Kidney Dis. 41 336-42
12. Daniels B S and Hauser E B 1992 Glycation of albumin, not glomerular basement membrane, alters permeability in an in vitro model Diabetes 41 1415-21
13. de Jong P E and Curhan G C 2006 Screening, monitoring, and treatment of albuminuria: public health perspectives J. Am. Soc. Nephrol. 17 2120-6
14. Gerdemann A, Wagner Z, Solf A, Bahner U, Heidland A, Vienken J and Schinzel R 2002 Plasma levels of advanced glycation end products during haemodialysis, haemodiafiltration and haemofiltration potential importance of dialysate quality Nephrol. Dial. Transplant. 17 1045-9
15. Gerstein H C et al and the HOPE Study Investigators 2001 Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals JAMA 286 421-6
16. Ghiggeri G M, Candiano G, Delfino G, Bianchini F and Queirolo C 1984 Glycosyl albumin and diabetic microalbuminuria demonstration of an altered renal handling Kidney Int. 25 565-70
17. Hillege H L, Fidler V, Diercks G F, van Gilst W H, de Zeeuw D, van Veldhuisen D J, Gans R O, Janssen W M, Grobbee D E, de Jong P E and the Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group 2002 Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population Circulation 106 1777-82
18. Hilliard L M, Osicka T M, Clavant S P, Robinson P J, Nikolic-Paterson D J and Comper W D 2006 The analysis and characterization of immuno-unreactive urinary albumin in healthy volunteers Clin. Biochem. 39 143-51
19. McCance D R, Dyer D G, Dunn J A, Bailie K E, Thorpe S R, Baynes J W and Lyons T J 1993 Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus J. Clin. Invest. 91 2470-8
20. Méndez J D, Xie J and García-Pérez E 2007 Urea inhibits the in vitro formation of fluorescent advanced glycation end products World Appl. Sci. J. 2 90-8
21. Mogensen C E 1987 Microalbuminuria as a predictor of clinical diabetic nephropathy Kidney Int. 31 673-89
22. Molnr G A et al 2005 Urinary ortho-tyrosine excretion in diabetes mellitus and renal failure evidence for hydroxyl radical production Kidney Int. 68 2281-7
23. Monnier V M and Cerami A 1981 Nonenzymatic browning in vivo possible process for aging of long-lived proteins Science 211 491-3
24. Ohmacht R and Kiss I 1996 Application of a new non-porous stationary phase (Kovasil-H) for the fast separation of peptides by HPLC Chromatographia 42 595-8
25. Osicka T M and Comper W D 2004 Characterization of immunochemically nonreactive urinary albumin Clin. Chem. 50 2286-91
26. Parving H H, Oxenboll B, Svendsen P A, Christiansen J S and Andersen A R 1982 Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion Acta Endocrinol. (Copenh.) 100 550-5
27. Rossing P, Hougaard P, Borch-Johnsen K and Parving H H 1996 Predictors of mortality in insulin dependent diabetes 10 year observational follow up study BMJ 313 779-84
28. Shinohara M, Thornalley P J, Giardino I, Beisswenger P, Thorpe S R, Onorato J and Brownlee M 1998 Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis J. Clin. Invest. 101 1142-7
29. Suzuki D, Yagame M, Naka R, Jinde K, Endoh M, Nomoto Y, Sakai H, Araki N and Horiuchi S 1995 Immunohistochemical staining of renal biopsy samples in patients with diabetic nephropathy in non-insulin dependent diabetes mellitus using monoclonal antibody to advanced glycation end products Nephrology 1 199-205
30. Sviridov D, Meilinger B, Drake S K, Hoehn G T and Hortin G L 2006 Coelution of other proteins with albumin during size-exclusion HPLC Implications for analysis of urinary albumin Clin. Chem. 52 389-97
31. Wagner Z, Wittmann I, Mazk I, Schinzel R, Heidland A, Kientsch-Engel R and Nagy J 2001 N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes role of renal function Am. J. Kidney Dis. 38 785-91
32. Westwood M E and Thornalley P J 1995 Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins J. Protein Chem. 14 359-72
33. Williams S K and Siegal R K 1985 Preferential transport of non-enzymatically glucosylated ferritin across the kidney glomerulus Kidney Int. 28 146-52
34. Yanagisawa K, Makita Z, Shiroshita K, Ueda T, Fusegawa T, Kuwajima S, Takeuchi M and Koike T 1998 Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients Metabolism 47 1348-53